Buscopan and Ms contin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Buscopan (hyoscine butylbromide) and Ms contin (morphine sulfate). Common drug interactions include malignant neoplasm progression among females and hypoaesthesia among males.

The phase IV clinical study analyzes what interactions people have when they take Buscopan and Ms contin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Buscopan?

Buscopan has active ingredients of hyoscine butylbromide. eHealthMe is studying from 4,828 Buscopan users. Check the latest studies of Buscopan.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

14 people who take Buscopan and Ms contin together, and have interactions are studied.

Buscopan and Ms contin drug interactions.

What are the common drug interactions of Buscopan and Ms Contin, by gender? *:

female:

Malignant neoplasm progression (cancer tumour came back)
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Neutropenia (an abnormally low number of neutrophils)
Oedema peripheral (superficial swelling)
Pneumonia
Pyelonephritis (inflammation of kidney caused by bacteria)
Cervix carcinoma (cancer of cervix)
Nausea (feeling of having an urge to vomit)
Somnolence (a state of near-sleep, a strong desire for sleep)
Thirst

male:

Hypoaesthesia (reduced sense of touch or sensation)
Insomnia (sleeplessness)
Liver disorder (liver diseases)
Malaise (a feeling of general discomfort or uneasiness)
Malignant neoplasm progression (cancer tumour came back)
Metastases to bone (cancer spreads to bone)
Nausea (feeling of having an urge to vomit)
Neoplasm malignant (cancer tumour)
Neutrophil percentage increased
Oesophageal candidiasis (fungal infection of oesophagus)

What are the common drug interactions of Buscopan and Ms Contin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Chills (felling of cold)
Hypoaesthesia (reduced sense of touch or sensation)
Malignant neoplasm progression (cancer tumour came back)
Pyrexia (fever)

30-39:

Chest pain
Dyspnoea (difficult or laboured respiration)
Hypoaesthesia (reduced sense of touch or sensation)
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Poor venous access

40-49:

n/a

50-59:

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Neutropenia (an abnormally low number of neutrophils)
Oedema peripheral (superficial swelling)
Cardiac flutter (abnormal heart rhythm)
Infusion related reaction
Malignant neoplasm progression (cancer tumour came back)

60+:

Malignant neoplasm progression (cancer tumour came back)
Pneumonia
Inflammation
Insomnia (sleeplessness)
Liver disorder (liver diseases)
Neutrophil percentage increased
Vomiting
Pyelonephritis (inflammation of kidney caused by bacteria)
Cervix carcinoma (cancer of cervix)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Cancer Pain: 6 people, 42.86%
Insomnia (sleeplessness): 4 people, 28.57%
Constipation: 4 people, 28.57%
Nausea And Vomiting: 3 people, 21.43%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 21.43%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 3 people, 21.43%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 21.43%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 21.43%
Dry Skin: 3 people, 21.43%
Diarrhea: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Buscopan and Ms contin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously